Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 616 to 630 of 1291 results for position

  1. Standards and indicators

    We have a library of over 200 quality standards and a single menu of indicators, designed to help define and measure quality in health, public health and social care.

  2. Subscribe to our GP reference panel

    Subscribe to our GP reference panel and contribute to the development of NICE guidance in a quick and easy way.

  3. Erlotinib and gefitinib for treating non-small-cell lung cancer that has progressed after prior chemotherapy (TA374)

    Evidence-based recommendations on erlotinib (Tarceva) and gefitinib (Iressa) for treating non-small-cell lung cancer after chemotherapy in adults.

    Technology appraisal guidance
    Published
    16 December 2015
    View recommendations

    Sections for TA374

  4. Payments and expenses

    Guide for lay members who we've invited to sit on one of NICE's committees, panels, or groups.

  5. IHI and H2020 Grant funded projects

    IMI and H2020 Grant funded projects with NICE

  6. How voluntary and community sector organisations can help us develop guidance

    How voluntary and community sector (VCS) organisations can help NICE develop guidance

  7. Payments and expenses

    Guide for lay members who we've invited to sit on one of NICE's committees, panels, or groups.

  8. How voluntary and community sector organisations can help us develop guidance

    How voluntary and community sector (VCS) organisations can help NICE develop guidance

  9. Stage 2: clinical assessment

    In a virtual ward setting, you make assessments at home to support clinical decision-making. Our guidance can help you give advice by highlighting areas to consider and standards of care.

  10. ThermoCool SmartTouch catheter for percutaneous radiofrequency ablation in atrial fibrillation (MIB61)

    NICE has developed a medtech innovation briefing (MIB) on the ThermoCool SmartTouch catheter for percutaneous radiofrequency ablation in atrial fibrillation

    Medtech innovation briefing
    Published
    23 March 2016

  11. Padeliporfin for untreated localised prostate cancer (TA546)

    Evidence-based recommendations on padeliporfin (Tookad) for untreated, unilateral, low-risk prostate cancer in adults.

    Technology appraisal guidance
    Published
    21 November 2018
    View recommendations

    Sections for TA546

  12. Ribociclib with an aromatase inhibitor for previously untreated, hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer (TA496)

    Evidence-based recommendations on ribociclib (Kisqali) as initial endocrine-based therapy for hormone-receptor positive, human epidermal growth factor receptor 2 (HER2)-negative, locally advanced or metastatic (secondary) breast cancer in adults.

    Technology appraisal guidance
    Published
    20 December 2017

    Sections for TA496

  13. Tools for building or evaluating an evidence base

    Tools for building or evaluating a medtech evidence base with NICE

  14. About NICE International

    We provide an advisory service for international health organisations, ministries and government agencies whose task is to improve evidence-based decision making in health and social care.

  15. Transparency of spend

    NICE transparency of spend